SE403377B - Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan - Google Patents
Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkanInfo
- Publication number
- SE403377B SE403377B SE7316586A SE7316586A SE403377B SE 403377 B SE403377 B SE 403377B SE 7316586 A SE7316586 A SE 7316586A SE 7316586 A SE7316586 A SE 7316586A SE 403377 B SE403377 B SE 403377B
- Authority
- SE
- Sweden
- Prior art keywords
- disposal
- therapeutic
- procedure
- special
- analgetic effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31322172A | 1972-12-08 | 1972-12-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE403377B true SE403377B (sv) | 1978-08-14 |
Family
ID=23214841
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7316586A SE403377B (sv) | 1972-12-08 | 1973-12-07 | Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan |
SE7701795A SE417196B (sv) | 1972-12-08 | 1977-02-17 | Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer |
SE7701796A SE428378B (sv) | 1972-12-08 | 1977-02-17 | Analogiforfarande for framstellning av droxanderivat |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7701795A SE417196B (sv) | 1972-12-08 | 1977-02-17 | Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer |
SE7701796A SE428378B (sv) | 1972-12-08 | 1977-02-17 | Analogiforfarande for framstellning av droxanderivat |
Country Status (27)
Country | Link |
---|---|
JP (2) | JPS5734835B2 (sv) |
AR (3) | AR206306A1 (sv) |
AT (2) | AT330773B (sv) |
BE (1) | BE808340A (sv) |
BG (4) | BG21223A3 (sv) |
CA (2) | CA1014560A (sv) |
CH (4) | CH605903A5 (sv) |
CS (3) | CS193480B2 (sv) |
CY (1) | CY1017A (sv) |
DD (3) | DD110864A5 (sv) |
DE (1) | DE2361340C2 (sv) |
DK (1) | DK134717B (sv) |
ES (4) | ES421290A1 (sv) |
FR (1) | FR2209578B1 (sv) |
GB (2) | GB1455998A (sv) |
HK (1) | HK60479A (sv) |
HU (2) | HU168763B (sv) |
IE (1) | IE40226B1 (sv) |
IL (1) | IL43773A (sv) |
KE (1) | KE2976A (sv) |
MY (1) | MY8000064A (sv) |
NL (1) | NL7316839A (sv) |
PH (2) | PH15197A (sv) |
SE (3) | SE403377B (sv) |
SU (4) | SU578001A3 (sv) |
YU (3) | YU35447B (sv) |
ZA (1) | ZA739207B (sv) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9376409B2 (en) * | 2012-05-09 | 2016-06-28 | Boehringer Ingelheim International Gmbh | Methods for making oxetan-3-ylmethanamines |
LV14983B (lv) * | 2013-10-15 | 2015-06-20 | Olainfarm, A/S | Fenibuta ražošanas starpproduktu iegūšanas paņēmiens |
-
1973
- 1973-01-01 AR AR251422A patent/AR206306A1/es active
- 1973-12-04 IE IE2190/73A patent/IE40226B1/xx unknown
- 1973-12-04 ZA ZA00739207A patent/ZA739207B/xx unknown
- 1973-12-06 PH PH15299A patent/PH15197A/en unknown
- 1973-12-06 CA CA187,516A patent/CA1014560A/en not_active Expired
- 1973-12-07 ES ES73421290A patent/ES421290A1/es not_active Expired
- 1973-12-07 FR FR7343848A patent/FR2209578B1/fr not_active Expired
- 1973-12-07 IL IL43773A patent/IL43773A/xx unknown
- 1973-12-07 NL NL7316839A patent/NL7316839A/xx not_active Application Discontinuation
- 1973-12-07 CA CA187,636A patent/CA1024150A/en not_active Expired
- 1973-12-07 YU YU3184/73A patent/YU35447B/xx unknown
- 1973-12-07 CH CH1720973A patent/CH605903A5/xx not_active IP Right Cessation
- 1973-12-07 HU HUEI511A patent/HU168763B/hu unknown
- 1973-12-07 AT AT1026073A patent/AT330773B/de not_active IP Right Cessation
- 1973-12-07 YU YU3185/73A patent/YU36171B/xx unknown
- 1973-12-07 HU HUEI510A patent/HU168620B/hu unknown
- 1973-12-07 SU SU7301978316A patent/SU578001A3/ru active
- 1973-12-07 CH CH1720873A patent/CH619219A5/de not_active IP Right Cessation
- 1973-12-07 AR AR251423A patent/AR212416A1/es active
- 1973-12-07 DK DK663373AA patent/DK134717B/da not_active IP Right Cessation
- 1973-12-07 BE BE1005568A patent/BE808340A/xx not_active IP Right Cessation
- 1973-12-07 ES ES73421291A patent/ES421291A1/es not_active Expired
- 1973-12-07 SU SU731977567A patent/SU587861A3/ru active
- 1973-12-07 AT AT1026173A patent/AT332396B/de not_active IP Right Cessation
- 1973-12-07 SE SE7316586A patent/SE403377B/sv unknown
- 1973-12-07 CH CH17977A patent/CH614439A5/xx not_active IP Right Cessation
- 1973-12-08 BG BG025193A patent/BG21223A3/xx unknown
- 1973-12-08 DE DE2361340A patent/DE2361340C2/de not_active Expired
- 1973-12-08 JP JP14024573A patent/JPS5734835B2/ja not_active Expired
- 1973-12-08 JP JP48140246A patent/JPS5742633B2/ja not_active Expired
- 1973-12-08 BG BG027548A patent/BG22386A3/xx unknown
- 1973-12-08 BG BG028632A patent/BG26205A4/xx unknown
- 1973-12-08 BG BG028633A patent/BG21409A3/xx unknown
- 1973-12-10 GB GB2900376A patent/GB1455998A/en not_active Expired
- 1973-12-10 GB GB5711373A patent/GB1455997A/en not_active Expired
- 1973-12-10 CS CS738528A patent/CS193480B2/cs unknown
- 1973-12-10 DD DD175232A patent/DD110864A5/xx unknown
- 1973-12-10 CS CS738529A patent/CS222208B2/cs unknown
- 1973-12-10 DD DD179119*A patent/DD115653A5/xx unknown
- 1973-12-10 DD DD175231A patent/DD109625A5/xx unknown
- 1973-12-10 CS CS765892A patent/CS222209B2/cs unknown
- 1973-12-10 CY CY1017A patent/CY1017A/xx unknown
-
1975
- 1975-01-27 SU SU752100370A patent/SU648081A3/ru active
- 1975-02-19 SU SU752106121A patent/SU663305A3/ru active
- 1975-05-14 AR AR258799A patent/AR212012A1/es active
-
1976
- 1976-01-28 ES ES444716A patent/ES444716A1/es not_active Expired
- 1976-02-04 ES ES444911A patent/ES444911A1/es not_active Expired
- 1976-04-30 PH PH18384A patent/PH14923A/en unknown
-
1977
- 1977-02-17 SE SE7701795A patent/SE417196B/sv unknown
- 1977-02-17 SE SE7701796A patent/SE428378B/sv unknown
-
1979
- 1979-07-03 KE KE2976A patent/KE2976A/xx unknown
- 1979-08-23 HK HK604/79A patent/HK60479A/xx unknown
- 1979-09-06 CH CH805879A patent/CH630914A5/de not_active IP Right Cessation
-
1980
- 1980-04-22 YU YU1093/80A patent/YU36020B/xx unknown
- 1980-12-30 MY MY64/80A patent/MY8000064A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO780402L (no) | Fremgangsmaate ved fremstilling av benzodiazepinderivater | |
SE417968B (sv) | Forfarande for framstellning av penamderivat | |
SE395149B (sv) | Forfarande for framstellning av dibenso-tiepinylpiperazinderivat | |
SE402283B (sv) | Karbazoler med antiinflammatorisk, analgetisk och antireumatisk verkan | |
SE381047B (sv) | Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat | |
SE401676B (sv) | Forfarande for framstellning av dibensofuranderivat | |
FI54312C (fi) | Foerfarande foer framstaellning av tieno-(2,3-d)pyrimidinderivat med avsoendring av urinsyra i urin utoekande | |
AR214383A1 (es) | Derivados de dialquilfosfanatos | |
SE399425B (sv) | Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat | |
SE402102B (sv) | Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper | |
SE397827B (sv) | Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan | |
AR207750A1 (es) | Procedimiento para la preparacion de derivados de benzo o naftofurano | |
AR201288A1 (es) | Derivados de alfa-cianmetansulfonamidobenceno | |
SE392722B (sv) | Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan | |
SE399557B (sv) | Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat | |
SE403377B (sv) | Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan | |
SE400767B (sv) | Forfarande for framstellning av arylpiperazin-derivat av adenin | |
SE385696B (sv) | Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper | |
AR195913A1 (es) | Procedimiento para la produccion de derivados 6-piperazinilicos de morfantridina y de analogos heterociclicos de la misma | |
SE400287B (sv) | Forfarande for framstellning av fluorsubstituerade tiaxantenderivat | |
SE394429B (sv) | Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan | |
SE393980B (sv) | Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan | |
AR205097A1 (es) | Procedimiento para la elaboracion de nuevos derivados de diazepina | |
SE391516B (sv) | Forfarande for framstellning av bensylaminderivat | |
NO144069C (no) | Difluorbutyrofenonderivater som er anvendelige for fremstilling av terapeutisk aktive butyrofenonderivater |